1. Home
  2. STVN vs LEVI Comparison

STVN vs LEVI Comparison

Compare STVN & LEVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STVN
  • LEVI
  • Stock Information
  • Founded
  • STVN 1949
  • LEVI 1853
  • Country
  • STVN Italy
  • LEVI United States
  • Employees
  • STVN N/A
  • LEVI N/A
  • Industry
  • STVN Containers/Packaging
  • LEVI Apparel
  • Sector
  • STVN Consumer Discretionary
  • LEVI Consumer Discretionary
  • Exchange
  • STVN Nasdaq
  • LEVI Nasdaq
  • Market Cap
  • STVN 6.2B
  • LEVI 6.8B
  • IPO Year
  • STVN 2021
  • LEVI 2019
  • Fundamental
  • Price
  • STVN $20.84
  • LEVI $18.40
  • Analyst Decision
  • STVN Buy
  • LEVI Buy
  • Analyst Count
  • STVN 6
  • LEVI 11
  • Target Price
  • STVN $27.50
  • LEVI $21.27
  • AVG Volume (30 Days)
  • STVN 358.7K
  • LEVI 2.4M
  • Earning Date
  • STVN 03-06-2025
  • LEVI 04-02-2025
  • Dividend Yield
  • STVN 0.28%
  • LEVI 2.83%
  • EPS Growth
  • STVN N/A
  • LEVI N/A
  • EPS
  • STVN 0.48
  • LEVI 0.52
  • Revenue
  • STVN $1,220,254,294.00
  • LEVI $6,355,300,000.00
  • Revenue This Year
  • STVN N/A
  • LEVI $1.58
  • Revenue Next Year
  • STVN N/A
  • LEVI $4.60
  • P/E Ratio
  • STVN $43.96
  • LEVI $35.37
  • Revenue Growth
  • STVN 3.53
  • LEVI 2.85
  • 52 Week Low
  • STVN $16.56
  • LEVI $15.62
  • 52 Week High
  • STVN $34.00
  • LEVI $24.34
  • Technical
  • Relative Strength Index (RSI)
  • STVN 47.73
  • LEVI 52.96
  • Support Level
  • STVN $18.37
  • LEVI $17.70
  • Resistance Level
  • STVN $20.38
  • LEVI $18.83
  • Average True Range (ATR)
  • STVN 1.24
  • LEVI 0.57
  • MACD
  • STVN -0.07
  • LEVI -0.04
  • Stochastic Oscillator
  • STVN 54.53
  • LEVI 42.94

About STVN Stevanato Group S.p.A.

Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables. and its other segment is Engineering. Geographically, the company derives majority revenue from Europe, Middle East and Africa.

About LEVI Levi Strauss & Co

Levi Strauss & Co is involved in designing, marketing, and selling products that include jeans, casual and dresses pants, tops, shorts, skirts, jackets, footwear, and related accessories directly or through third parties and licensees for men, women, and children under Levi's, Dockers, Signature by Levi Strauss & Co. and Denizen brands. The company manages its business according to three regional segments: the Americas, which is the key revenue driver; Europe; and Asia.

Share on Social Networks: